Atlas Trials

A Survival Observational Study in Patients With Advanced IIIB-IV Squamous Cell Lung Cancer Receiving PD-1 Combination With Chemotherapy

Clinical trial NCT04306042 · UNKNOWN

Trial details

NCT number
NCT04306042
Sponsor
Guangdong Association of Clinical Trials
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Squamous Cell Carcinoma Stage IV
Start date
2020-03-01
Primary completion
2020-12-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.